Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,197,244
-
Share change
-
-3,027,969
-
Total reported value
-
$2,319,000
-
Price per share
-
$0.72
-
Number of holders
-
20
-
Value change
-
-$3,251,822
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q2 2019
As of 30 Jun 2019,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,197,244 shares.
The largest 10 holders included
VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., PURA VIDA INVESTMENTS, LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., GEODE CAPITAL MANAGEMENT, LLC, HighTower Advisors, LLC, D.A. DAVIDSON & CO., NORTHERN TRUST CORP, Parallax Volatility Advisers, L.P., and WELLS FARGO & COMPANY/MN.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.